logo
Nervous bosses to use Tasers for protection after UnitedHealthcare assassination

Nervous bosses to use Tasers for protection after UnitedHealthcare assassination

Telegraph05-03-2025
The company that makes Tasers is poised to roll out a 'covert' weapon to satisfy a surge in demand from nervous chief executives after the head of America's biggest health insurer was shot dead in New York.
Axon has told investors that fear among corporate bosses in the wake of the assassination presented a huge growth opportunity for the company.
Brian Thompson, who led UnitedHealth Group's insurance arm, was gunned down outside the entrance to the New York Hilton Midtown in December last year.
Josh Isner, the president of Axon Enterprise, said it had received a flurry of inquiries from private firms since Thompson's killing, resulting in Axon developing a 'more covert' device adapted for 'an executive security-type scenario'.
He told Semafor: 'Over the next year, you might start to hear more about certain chief executives being protected by Taser.'
Axon is best known for supplying the Taser, a weapon that fires barbs attached to wires which deliver an incapacitating electric shock, to law enforcement officials.
In the aftermath of the attack on the 50-year-old father of two, police officers were seen patrolling outside executives' homes with some even hiring private security.
The ramping up of security has been accompanied by greater concerns over privacy, with photos and bios of some executives being removed while public meetings have been held virtually for security reasons.
Axon also owns the counter-drone defence technology company Dedrone, which it bought in October last year. The manufacturer lists airports, correctional facilities, critical infrastructure, military and VIPs as its clients.
The firm has supplied Swiss Police with a security program for the Global Economic Forum in Davos, Switzerland, and offers 'smart airspace security for VIPs' such as the royal family of Qatar.
'Think about how easy it is to equip a drone with something bad and fly it into something,' Mr Isner said.
Axon announced last week that annual revenues had doubled over the past two years to $2.1bn (£1.7bn) amid booming demand from retailers for body cameras and in-store security cameras to combat rising shoplifting.
Mr Isner said Axon had signed an 'eight-figure deal' with Loblaws, Canada's largest supermarket chain, last year. In an earnings call last week, he also announced the company had secured the largest contract in its history with an unnamed logistics company.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dow ends higher after UnitedHealth gains, other indexes slip on rate cut uncertainty
Dow ends higher after UnitedHealth gains, other indexes slip on rate cut uncertainty

Reuters

time3 days ago

  • Reuters

Dow ends higher after UnitedHealth gains, other indexes slip on rate cut uncertainty

NEW YORK, Aug 15 (Reuters) - The blue-chip Dow Jones ended higher after hitting an intraday record high on Friday, as UnitedHealth's shares jumped after Berkshire Hathaway raised its stake, but other Wall Street indexes slipped as mixed data clouded the Federal Reserve's next monetary policy move. A meeting between U.S. President Donald Trump and Russian counterpart Vladimir Putin was also on the radar, with markets hoping it could pave the way for a resolution to the Ukraine conflict and determine the outlook for crude prices. The two leaders began a meeting in Alaska on Friday afternoon. UnitedHealth Group (UNH.N), opens new tab rose sharply after Warren Buffett's company (BRKa.N), opens new tab revealed a new investment in the health insurer, while Michael Burry's Scion Asset Management also turned more bullish on the company. Rising costs in the broader healthcare sector and about a 40% slump in UnitedHealth's shares this year have left the Dow (.DJI), opens new tab lagging its Wall Street peers on the road to record highs. The price-weighted index last scaled an all-time high on December 4. The healthcare sector (.SPXHC), opens new tab gained on Friday, tracking its best weekly performance since October 2022. According to preliminary data, the S&P 500 (.SPX), opens new tab lost 18.86 points, or 0.29%, to end at 6,449.68 points, while the Nasdaq Composite (.IXIC), opens new tab lost 83.99 points, or 0.40%, to 21,626.68. The Dow Jones Industrial Average (.DJI), opens new tab rose 43.83 points, or 0.10%, to 44,955.09. More broadly, Wall Street's main stock indexes recorded their second week of gains, buoyed by expectations that the Fed could restart its monetary policy easing cycle with a 25-basis-point interest rate cut in September. The central bank last lowered borrowing costs in December and said U.S. tariffs could add to price pressures. However, recent labor market weakness and signs that tariff-induced inflation was yet to reflect in headline consumer prices have made investors confident of a potential dovish move next month. "The question is, has the tariff gotten into the price of goods yet? And it appears that there hasn't," said Joe Saluzzi, co-head of equity trading at Themis Trading. Saluzzi also said while markets have largely priced in a September rate cut, investors might be overlooking risks, with low volatility and rich valuations pointing to a sense of complacency. In a mixed day for economic data, a report showed retail sales in July rose as expected, but consumer confidence and factory production numbers indicated tariffs were taking a toll on other pockets of the economy. Chicago Fed President Austan Goolsbee was also cautionary in his remarks. Trump has said he will unveil tariffs on steel and semiconductors next week. Among other stocks that were on the move, Applied Materials (AMAT.O), opens new tab tumbled after the chip equipment maker issued weak fourth-quarter forecasts. Shares of Bank of America (BAC.N), opens new tab dropped after Berkshire Hathaway reduced its stake in the second-biggest U.S. lender by 4.2% to 605.3 million shares. It still owns about an 8% stake in BofA. Intel (INTC.O), opens new tab surged after a report said the Trump administration was in talks for the U.S. government to potentially take a stake in the chipmaker.

UnitedHealth surges after Warren Buffett bets on recovery
UnitedHealth surges after Warren Buffett bets on recovery

Reuters

time3 days ago

  • Reuters

UnitedHealth surges after Warren Buffett bets on recovery

Aug 15 (Reuters) - Shares of UnitedHealth Group (UNH.N), opens new tab surged more than 13% on Friday after billionaire Warren Buffett's Berkshire Hathaway (BRKa.N), opens new tab bought 5 million shares of the company, providing a shot in the arm for investors who think the health conglomerate will turn around under its new CEO. The shares have lost nearly half their value in the last year as the company struggled to adapt to rising healthcare costs and changes to government reimbursement plans that affected its health insurance and Optum patient care businesses. News of Buffett's stake, along with purchases by other large hedge fund managers, suggests investors believe the stock currently does not reflect its long-term outlook. However, the turnaround may be slow, as UnitedHealth reckons with billions of additional medical costs expected to hit in the coming quarters. The "vote of confidence" from Buffett validates UnitedHealth's long-term value, but "(the) management needs to regain trust and credibility with investors, and get back to its beat-and-raise reputation of the past," said James Harlow, senior vice president at Novare Capital Management. UnitedHealth missed Wall Street's earnings target for two straight quarters this year and was forced to pull back its 2025 outlook in May, rare moves for a company that had long been favored for its regular earnings growth. It reinstated the annual outlook last month, but the profit forecast was well short of analysts' already lowered estimate. The company's shares currently trade at about 15.8 times forward earnings estimates, below their five-year average of 19. The stock has dropped nearly 40% in 2025, making it the worst-performing stock on the blue-chip Dow Jones Industrial Average (.DJI), opens new tab this year. Friday's gains helped the Dow hit an all-time intraday high, while shares of rivals Humana (HUM.N), opens new tab, Elevance Health (ELV.N), opens new tab and CVS Health (CVS.N), opens new tab rose more modestly. "I'm a bit surprised at the magnitude of the stock move today but that shows how beaten up and out of favor the stock and entire health insurance sector is," Jeff Jonas, portfolio manager at Gabelli Funds said. In the last two years, the company has dealt with fallout from a cyberattack at its technology unit that served as a major backbone in the U.S. healthcare system, the murder of its insurance unit chief in December, and a federal investigation into its government-backed health plans. In May, CEO Andrew Witty abruptly resigned in the face of the worsening operational issues, and Stephen Hemsley, who had run the company from 2006 to 2017, took over. Buffett is known as a patient and opportunistic investor, swooping in with big investments in companies during periods of struggle when he sees a long-term strategic value. He invested heavily in Occidental Petroleum (OXY.N), opens new tab in 2019 as it tried to finance a merger with Anadarko Petroleum and has kept adding to his stake despite the company's weak stock performance. He famously took a stake in investment bank Goldman Sachs (GS.N), opens new tab at the height of the global financial crisis in 2008. "Buffett's purchase is a psychological reassurance to many investors that saw UnitedHealth as 'untouchable,' given the massive turbulence in the stock over the past few months," said Kevin Gade, chief operating officer at UnitedHealth investor Bahl & Gaynor. Berkshire said in a U.S. Securities and Exchange Commission filing on Thursday that it owned 5.04 million UnitedHealth shares, worth about $1.57 billion, as of June 30. Buffett owned about 1.18 million shares in UnitedHealth between 2006 and 2009, before selling his entire stake in 2010. Several other prominent hedge funds, including David Tepper's Appaloosa Management, Lone Pine Capital and Two Sigma Investments, also bought UnitedHealth's shares, regulatory filings showed on Thursday. "While UnitedHealth still faces elevated uncertainty, it is good to see that this renowned investment firm also believes the market is discounting assumptions that are too pessimistic for the long term," said Morningstar analyst Julie Utterback.

Dow scales record high on hopes of Fed rate cuts, trade deals
Dow scales record high on hopes of Fed rate cuts, trade deals

Reuters

time3 days ago

  • Reuters

Dow scales record high on hopes of Fed rate cuts, trade deals

Aug 15 (Reuters) - The Dow Jones Industrial Average hit an all-time intraday high on Friday, making it the last of the three major U.S. indexes to clinch a record in Wall Street's rally fueled by the prospect of a looser monetary policy, easing trade tensions and upbeat corporate earnings. The Dow (.DJI), opens new tab briefly surpassed the previous peak of 45,073.63 touched on December 4, helped by a 9.5% jump in UnitedHealth Group shares (UNH.N), opens new tab after Warren Buffett's Berkshire Hathaway revealed a new investment in the health insurer. It was last up 0.3% at 45,062 points. Counted among the oldest and most followed indexes, the Dow tracks the performance of 30 U.S.-listed large-cap stocks. "We have certainly waited a long time this year for the Dow Jones industrial average to catch up and join the new high club with the Nasdaq and the S&P," said Art Hogan, chief market strategist at B. Riley Wealth. The blue-chip index is price-weighted rather than market-cap-weighted, differentiating it from indexes such as the S&P 500, for which companies with larger market values carry the most weight. The Dow's gains have been propelled by a solid year-to-date performances from Wall Street bank Goldman Sachs (GS.N), opens new tab, tech giant Microsoft (MSFT.O), opens new tab and industrial equipment maker Caterpillar (CAT.N), opens new tab. Chip designer and AI champion Nvidia (NVDA.O), opens new tab, which became the first publicly listed company to clinch $4 trillion in market capitalization, has also aided the Dow's rise. The stock has gained more than 30% this year. The S&P 500 (.SPX), opens new tab and the Nasdaq Composite (.IXIC), opens new tab reached all-time highs late June, thanks to renewed AI enthusiasm, hopes of U.S. trade deals and rising bets on interest rate cuts, which helped drive a turnaround in U.S. stocks from a sharp rout earlier this year. The Dow, however, has lagged in reaching record highs, as limited exposure to AI names and the underperformance of companies such as UnitedHealth Group and Salesforce (CRM.N), opens new tab restricted its overall increase. "Dow Jones has lagged the overall market because it has a lot of value companies in there, and this has not been a value market," said Dennis Dick, chief strategist at Stock Trader Network. The blue-chip index has jumped more than 20% since hitting this year's lowest in April when U.S. President Donald Trump announced sweeping "reciprocal tariffs" to rebalance the global trade order in favor of the United States. After a series of U.S. trade agreements with the UK, Japan, and the European Union, investors are certain that a worst-case global recession scenario can be avoided. Meanwhile, a weak labor market report for July prompted traders to increase their bets on an interest rate cut as early as September. Trump's moves to shake up the Federal Reserve leadership - including an interim pick for a Fed governor post and an expanded search to replace Chair Jerome Powell next year with someone willing to lower interest rates - have also added to rate cut bets. Health insurer UnitedHealth has been the biggest drag on the index. The company's stock has dropped more than 41% so far in 2025. Disappointing earnings, elevated medical costs, CEO Andrew Witty's abrupt departure, and an ongoing U.S. Department of Justice criminal investigation have contributed to a steep decline in its stock price. The Dow has risen nearly 6% so far this year. In comparison, the S&P 500 and the Nasdaq have risen about 10% and more than 12%, respectively. Other notable contributors in the Dow's rise this year include major lender JPMorgan Chase (JPM.N), opens new tab and planemaker Boeing (BA.N), opens new tab, which have risen about 22.6% and 31.6%, respectively, so far this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store